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How mutant prion protein (PrP) leads to neurological
dysfunction in genetic prion diseases is unknown.
Tg(PG14) mice synthesize a misfolded mutant PrP
which is partially retained in the neuronal endo-
plasmic reticulum (ER). As these mice age, they
develop ataxia and massive degeneration of cere-
bellar granule neurons (CGNs). Here, we report that
motor behavioral deficits in Tg(PG14) mice emerge
before neurodegeneration and are associated with
defective glutamate exocytosis from granule
neurons due to impaired calcium dynamics. We
found that mutant PrP interacts with the voltage-
gated calcium channel a2d-1 subunit, which pro-
motes the anterograde trafficking of the channel.
Owing to ER retention of mutant PrP, a2d-1 accumu-
lates intracellularly, impairing delivery of the channel
complex to the cell surface. Thus, mutant PrP
disrupts cerebellar glutamatergic neurotransmission
by reducing the number of functional channels in
CGNs. These results link intracellular PrP retention
to synaptic dysfunction, indicating new modalities
of neurotoxicity and potential therapeutic strategies.
INTRODUCTION
Evidence is emerging that neurological symptoms in prion
diseases precede neuronal loss and are due to an adverse effect
of misfolded prion protein (PrP) on synaptic function. Thera-
peutic intervention, therefore, requires identification of the
mechanisms by which abnormal PrP disrupts normal neuronal
activity. Here, we describe the mechanism underlying the neuro-300 Neuron 74, 300–313, April 26, 2012 ª2012 Elsevier Inc.transmission defect associated with early motor impairment in
transgenic (Tg) mouse models of genetic prion disease. This
has brought to light an unexpected effect of misfolded PrP on
the intracellular trafficking of voltage-gated calcium channels
(VGCCs).
Prion diseases, including Creutzfeldt-Jakob disease (CJD),
Gerstmann-Stra¨ussler-Scheinker syndrome, and fatal insomnia,
are rare neurodegenerative disorders characterized pathologi-
cally by neuronal loss, astrocytosis, and deposition of insoluble
PrP aggregates throughout the brain (Prusiner, 1998). They
usually involve loss of motor coordination and other motor
abnormalities, dementia and neurophysiological deficits, and
are invariably fatal (Knight and Will, 2004). Approximately 15%
of human prion diseases are inherited in an autosomal-dominant
fashion and are linked to point mutations or insertions in the gene
encoding PrP on chromosome 20 (Mastrianni, 2010). The neuro-
toxic pathways activated by mutant PrP are not clear, but mis-
folding and oligomerization of the mutant protein are thought
to trigger the pathogenic process (Chiesa and Harris, 2001).
Tg mice expressing a mouse PrP homolog of a 72 amino acid
insertion (PG14), which in humans is associated with progressive
dementia and ataxia, synthesize a misfolded form of mutant PrP
in their brains that is aggregated into small oligomers (Chiesa
et al., 1998, 2003). As thesemice age, they develop a fatal neuro-
logical disorder characterized clinically by ataxia, and neuropa-
thologically by cerebellar atrophy due to loss of synaptic endings
in the molecular layer and massive apoptosis of granule neurons
(Chiesa et al., 2000). Deletion of the proapoptotic gene Bax in
Tg(PG14) mice rescues cerebellar granule cells but does not
prevent synaptic loss in the molecular layer and development
of clinical symptoms (Chiesa et al., 2005); thus, mutant PrP
causes neurological disease by disrupting the normal neuronal
connectivity or function in the cerebellum. PG14 PrP molecules
misfold soon after synthesis in the endoplasmic reticulum (ER)
(Daude et al., 1997), and their exit from the ER is impaired
(Drisaldi et al., 2003). However, ER stress-related pathways are
Figure 1. Tg(PG14) Mice Develop Deficits in Motor and Balance
Coordination before Cerebellar Degeneration
(A) Groups of 6–15 Tg(WT), 7–12 Tg(PG14) mice, and 6–17 non-Tg littermates
were tested on a Rotarod at the ages indicated. Each mouse was tested three
times. Bars indicate the mean ± SEM latency to fall (s); **p < 0.01, ***p < 0.001
versus Tg(WT) by one-way analysis of variance (ANOVA), Bonferroni’s post
hoc test.
(B) Brain anatomy of non-Tg, Tg(WT), and Tg(PG14)mice at the ages indicated.
Representative T2-weighted images (TE/TR = 50/2,500 ms).
(C) Cerebellar volumes (mm3) of non-Tg, Tg(WT), and Tg(PG14) mice at the
ages indicated. Mean ± SD. The number of animals is given in parentheses.
****p < 0.0001 versus non-Tg and Tg(WT) by two-way ANOVA, Bonferroni’s
post hoc test.
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retention of PG14 PrP may trigger some other pathogenic
mechanisms.
Here, we report that motor behavioral deficits in Tg(PG14)
mice emerge before neurodegeneration and are associated
with defective depolarization-induced glutamate exocytosis
from cerebellar granule neurons (CGNs). Altered calcium influx
due to inefficient membrane delivery of VGCCs accounts for
the exocytosis defect and is causally linked to intracellular reten-
tion ofmutant PrP. Confirming this, alterations in VGCC transport
and glutamate exocytosis are also found in cells and in Tg mice
expressing a mouse PrP homolog of the D178N mutation linkedto inherited CJD. These results provide new insights into the
mechanism of neuronal dysfunction in genetic prion diseases.
RESULTS
Tg(PG14) Mice Develop Early Impairment in Motor
and Balance Coordination Associated with Low
Glutamate Release in the Cerebellum
The Tg(PG14) mice used in this study express mutant PrP at
a level similar to endogenous PrP in wild-typemice; they develop
ataxia, kyphosis, and foot clasp reflex at 240 days of age and
die prematurely at 450 days (Chiesa et al., 1998, 2000).
To find out the earliest appearance of motor dysfunction,
Tg(PG14) mice were tested on the accelerating Rotarod. This
motor behavioral task requires the mice to walk on an acceler-
ating rotating rod with latency to fall as readout, and is a sensitive
indicator of cerebellar abnormalities (Hilber and Caston, 2001;
Yamamoto et al., 2003). Tg(PG14) mice performed well between
19 and 25 days of age (see Figure S1A available online), confirm-
ing normal postnatal development of the cerebellum (which is
completed in the third week of life) and motor learning (Chiesa
et al., 2000). From 45 days on, however, the mice showed
a significantly shorter latency to fall than non-Tg littermates
and Tg(WT) mice expressing wild-type PrP (Chiesa et al.,
1998); their performance worsened with aging until they became
virtually unable to perform the task (Figure 1A).
We used MRI to see whether the emergence of the motor
deficit was associated with cerebellar degeneration. Tg(PG14)
mice were examined at 50 and 250 days of age, with age-
matched non-Tg and Tg(WT) controls. At 50 days the cerebellar
volume of Tg(PG14) mice was comparable to controls (Figures
1B and 1C). In older Tg(PG14) mice there was a significant
atrophy of the cerebellum (Figures 1B and 1C), consistent with
previous histological analysis showing age-dependent cere-
bellar degeneration (Chiesa et al., 2000).
To investigate changes in cerebellar synaptic structures, we
immunostained the brains of young and old animals with an
antibody against the vesicular glutamate transporter VGLUT1,
which specifically labels glutamatergic projections of CGNs in
the molecular layer of the cerebellum (Fremeau et al., 2001).
There was no difference in VGLUT1 immunostaining between
young non-Tg and Tg(PG14) mice, whereas a significant
decrease was seen in older Tg(PG14) mice (Figures S1B–S1D).
There were also no differences between 50-day-old non-Tg
and Tg(PG14) mice in the levels of the synaptic vesicle-associ-
ated proteins synaptophysin and synapsin I, the SNARE protein
SNAP-25, the synaptic vesicle fusion protein synaptotagmin I,
and the secretory vesicle chaperone CSPa (data not shown),
confirming that there was no synaptic degeneration at this stage.
To identify abnormalities in cerebellar neurotransmission, we
did functional studies in purified synaptosomal fractions. Synap-
tosomes were isolated from the cerebellum and cerebral cortex
of Tg(WT) and Tg(PG14) mice, and characterized biochemically
(Figures S2A–S2C). Synaptosomal PG14 PrP was detergent
insoluble (seen in the pellet fraction after ultracentrifugation,
Figures S2D and S2E), and was immunoprecipitated by mono-
clonal antibody 15B3 (Figure S2F), which selectively recognizes
aggregated forms of misfolded PrP (Biasini et al., 2009). WeNeuron 74, 300–313, April 26, 2012 ª2012 Elsevier Inc. 301
Figure 2. Cerebellar Tg(PG14) Synaptosomes Show Impaired Depolarization-Evoked Glutamate Release and Calcium Influx
(A) Cerebellar synaptosomes from 230- to 250-day-old mice were preloaded with [3H]D-aspartate and stratified on filters in a 20 chamber superfusion apparatus.
After equilibration, synaptosomes were exposed to 15 mM KCl for 1.5 min. The K+-induced [3H]D-aspartate overflow was measured in the collected fractions.
Each error bar indicates the mean ± SEM of 5–20 replicate chambers from 2 to 4 independent experiments. Data are expressed as percentages of the values of
Tg(WT) mice. *p < 0.05 versus corresponding value in Tg(WT) by Student’s t test.
(B) K+-induced release was determined in cerebellar synaptosomes from Tg(WT) and Tg(PG14) mice of the ages indicated. Each bar indicates the mean ± SEM
of 5–14 replicates from 1 to 3 independent experiments. *p < 0.05 and **p < 0.01 by Student’s t test.
(C) Depolarization-induced release was determined in synaptosomes from the cerebral cortex of the same Tg(WT) and Tg(PG14) mice used in (B). Each bar
indicates the mean ± SEM. *p < 0.05 versus corresponding value of Tg(WT) by Student’s t test.
(D) Cerebellar synaptosomes were preloaded with fura-2 AM and depolarized with 50mMKCl. The K+-induced [Ca2+]i rise is expressed as percentDF (difference
of the fluorescence ratio F340/380 before and after the stimulus) of K+-induced calcium responses in synaptosomes of Tg(WT) mice. Each bar indicates
the mean ± SEM of 9–21 replicates from 2 to 4 independent synaptosomal preparations pooling 13 Tg(WT), 12 Tg(PG14), 4 Prnp0/0, and 4 Prnp+/+ mice of 230–
250 days. *p < 0.05 and ***p < 0.001 versus corresponding value for Tg(WT) by Student’s t test.
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GABA, which are the main excitatory and inhibitory neurotrans-
mitters in the cerebellum. There were no differences in [3H]gluta-
mate and [3H]GABA uptake or spontaneous or depolarization-
induced [3H]GABA release between Tg(WT) and Tg(PG14) mice
up to 300 days old (data not shown). To assess release from
glutamatergic terminals, we used [3H]D-aspartate, a nonmetabo-
lizable analog of glutamate (Stigliani et al., 2006). We found
a significant reduction in depolarization-induced release in
the cerebellar synaptosomes from Tg(PG14) mice compared
to Tg(WT), PrP knockout (Prnp0/0), and C57BL/6 (Prnp+/+) mice
(Figure 2A). Release was already significantly reduced in cere-
bellar synaptosomes from 30- to 70-day-old animals, correlating
with the onset of the motor deficit, and was almost completely
impaired by the time mice had advanced clinical disease (Fig-
ure 2B). In the cerebral cortex a significant decrease in [3H]D-
aspartate release was found only in mice between 134 and
162 days old (Figure 2C).
Defective Glutamate Release Is Due to Impaired VGCC
Function in CGNs
Depolarization induces neurotransmitter release from synaptic
terminals by triggering calcium influx through the VGCC, fol-
lowed by exocytosis of synaptic vesicles (Sudhof, 2004). To
determine whether the release defect in the cerebellum of302 Neuron 74, 300–313, April 26, 2012 ª2012 Elsevier Inc.Tg(PG14) mice was due to defective exocytosis, we used
ionomycin, a calcium ionophore that allows calcium influx
independently of VGCCs. Ionomycin evoked efficient calcium-
dependent [3H]D-aspartate release from PG14 cerebellar
synaptosomes unresponsive to depolarization (Figures S3A–
S3C), indicating that the glutamate exocytotic machinery func-
tioned normally in the mutant mice, and pointing to a VGCC
defect.
Next, we measured depolarization- and ionomycin-induced
calcium rise in synaptosomes preloaded with the calcium-sensi-
tive dye fura-2 AM. Depolarization-induced calcium influx was
significantly lower in PG14 cerebellar synaptosomes than in
controls (Figures 2D and S3D), whereas there was no difference
after stimulus with ionomycin (Figures S3E and S3F). No differ-
ence in depolarization-induced calcium rise was seen in synap-
tosomes from the cerebral cortex (data not shown).
Because CGNs are the main glutamatergic cell population in
the cerebellum, and specifically targeted in Tg(PG14) mice, we
reasoned that the defect could pertain to this cell type. We,
therefore, measured depolarization-evoked [3H]D-aspartate
release in primary CGN cultures from the Tg(PG14) mice.
Release was significantly lower in PG14 than in wild-type cells
(Figure 3A). Single-cell calcium imaging found impaired calcium
influx in response to depolarization (Figures 3B and 3C), and
whole-cell patch-clamp recordings showed reduced calcium
Neuron
Mutant PrP Alters Voltage-Gated Calcium Channelscurrent densities in PG14 CGNs (Figures 3D and 3E). There were
no apparent differences between wild-type and PG14 neurons in
VGCC activation and inactivation kinetics (Figure 3D), and in the
voltage dependence of activation (Figure 3F), suggesting
a reduction in the number of functional channels rather than
changes to their biophysical properties.
Evoked excitatory postsynaptic currents (EPSCs) recorded in
cultured PG14 CGN by dual whole-cell patch clamp were signif-
icantly smaller than in wild-type cells, supporting the view that
reduced calcium influx in themutant neurons impaired glutamate
release (Figures 3G and 3H). The decrease in EPSC amplitude
in PG14 neurons was not due to reduced postsynaptic sensitivity
to glutamate, as suggested by the increased amplitude (wild-
type = 12.07 ± 0.89 pA; PG14 = 16.51 ± 0.88 pA; mean ± SEM,
n = 14 for wild-type and n = 13 for PG14; p < 0.01 by Mann-
Whitney U test), and not frequency of miniature events (wild-
type = 0.34 ± 0.05 Hz; PG14 = 0.28 ± 0.03 Hz, mean ± SEM;
not significant by Mann-Whitney U test). The decrease in EPSC
amplitude was rather due to reduced presynaptic calcium
currents, as revealed by the increase in facilitation in a protocol
of short-term plasticity (Figure 3I), which is sensitive to the
amount of calcium entry (Zucker and Regehr, 2002). These
results, which are in line with previous reports for mutations of
calcium channels affecting excitatory synaptic transmission
(Liu and Friel, 2008; Ly et al., 2008; Qian and Noebels, 2000),
indicated abnormal VGCC function and impaired glutamatergic
neurotransmission in CGN of Tg(PG14) mice.
Defective Calcium Influx in CGNs Is Associated
with PG14 PrP Accumulation in Transport Organelles
We used two complementary approaches to demonstrate that
the VGCC defect was due to mutant PrP expression. First, we
tested whether silencing PG14 PrP expression by lentivector-
mediated RNAi restored the depolarization-induced calcium
rise in mutant CGNs. CGNs from Tg(PG14) mice were trans-
duced with a control lentivirus carrying enhanced green fluores-
cent protein (EGFP) cDNA (LV-E), or two different lentiviruses
encoding EGFP and anti-PrP shRNAs (LV-MW1 and LV-MW2)
that efficiently knock down PrP expression (Figure S4) (White
et al., 2008), and the intracellular calcium rise in response to
depolarization was measured in transduced neurons identified
by EGFP fluorescence. LV-MW1 and LV-MW2 significantly
enhanced the calcium rise in PG14 PrP-expressing but not
control cells (Figure 4A), indicating that knockdown of mutant
PrP rescued the cells from the calcium influx defect.
Second, we investigated whether PG14 PrP induced an
abnormal calcium response in wild-type neurons. CGNs from
C57BL/6J mice were transfected with a bigenic plasmid that
drives efficient PrP and EGFP expression in CGNs (Drisaldi
et al., 2004), and the depolarization-induced calcium rise was
measured in EGFP-positive cells. PG14 PrP-transfected cells
had a significantly smaller rise in calcium than untransfected or
wild-type PrP-transfected neurons (Figure 4B), indicating that
acute PG14 PrP expression was sufficient to impair VGCC
function.
The biosynthetic maturation of misfolded PG14 PrPmolecules
in the ER is delayed, and they accumulate in the neuronal secre-
tory pathway (Drisaldi et al., 2003; Fioriti et al., 2005). To assesswhether intracellular PG14 PrP retention plays a role in the VGCC
defect, we analyzed the depolarization-induced calcium rise in
CGNs transfected with a version of PG14 PrP with a deletion
of amino acids 114–121 in the hydrophobic core (PG14/DHC).
This molecule is less prone to misfolding and delivered to the
cell surface more efficiently than its full-length counterpart
(Biasini et al., 2010). CGNs from C57BL/6 mice were transfected
with PG14/DHC PrP, or with a version of PrP carrying the hydro-
phobic core deletion but not the PG14 mutation (DHC). The
calcium responses of PG14/DHC PrP-expressing cells were
comparable to those of the wild-type and DHC controls (Fig-
ure 4B), suggesting that misfolding and intracellular retention
of mutant PrP were necessary to induce the defect in calcium
influx.
PG14 PrP Impairs VGCC a2d-1 Subunit Trafficking
to the Plasma Membrane
Reduced intracellular calcium influx and current amplitude in
PG14 CGNs might be due to changes in VGCC expression,
biophysical properties, or membrane targeting. VGCCs are het-
eromeric proteins consisting of the pore-forming CaVa1 subunit,
which governs the biophysical and pharmacological properties
of the channel, and the auxiliary a2d and CaVb subunits, which
regulate the cellular trafficking and activity of CaVa1 (Dolphin,
2009). Glutamate release from CGNs is mainly governed by
P/Q-type channels made of the CaVa1A, a2d-1, and CaVb4
subunit isoforms (Mintz et al., 1995). To test whether expression
of these channels was altered in Tg(PG14) mice, we measured
CaVa1A and a2d-1 levels in cerebellar postnuclear supernatants
and cultured CGNs. There were no differences in these proteins
between Tg(PG14) and Tg(WT) mice (data not shown; Fig-
ure S7B), indicating that the calcium defect in the mutant mice
was not due to altered VGCC expression.
Because our data pointed to a role of intracellular PG14 PrP
retention, we hypothesized that mutant PrP interacted with
VGCCs in transport organelles, interfering with their trafficking
toward the plasmamembrane. Of the different channel subunits,
a2d-1 was the best candidate for an interaction with PrP
because PrP is a glycosylphosphatidylinositol (GPI)-anchored
sialoglycoprotein (Stahl et al., 1987) exposed on the outer leaflet
of the plasma membrane in cholesterol-rich microdomains
(also known as lipid rafts), and there is evidence that a2d-1 is
also GPI anchored (Davies et al., 2010). To test whether PrP
and a2d-1 interacted physically, we immunoprecipitated PrP
from cerebellar extracts of Tg(WT) and Tg(PG14) mice, and
immunoblotted the precipitated fractions with an antibody
raised against the a2 polypeptide of a2d-1. As shown in Figure 5A,
an immunoreactive band of 145 kDa was detected in immuno-
precipitates of Tg(WT) and Tg(PG14) but not in Prnp0/0 mice,
or when the immunoprecipitation was done in the absence of
the anti-PrP antibody. After deglycosylation with PNGaseF,
this band shifted to an apparent molecular weight of 107 kDa,
as expected for the a2 polypeptide (Figure S5A) (Davies et al.,
2006).
The interaction was confirmed in the reverse experiment in
which a2d-1 was immunoprecipitated from cerebellar extracts
and PrP detected by immunoblot (Figure 5B), and was also
seen in primary cultured CGNs (Figure S5B) and transientlyNeuron 74, 300–313, April 26, 2012 ª2012 Elsevier Inc. 303
Figure 3. Depolarization-Evoked [3H]D-Aspartate Release, CalciumCurrents, andGlutamatergicNeurotransmission Are Impaired in Primary
CGNs from Tg(PG14) Mice
(A) K+-induced [3H]D-aspartate release from primary cultures of CGNs from Tg(WT) and Tg(PG14) mice. Each value represents the mean ± SEM of 13–20
replicates from 3 independent experiments. *p < 0.05 by Student’s t test.
(B) CGNs preloaded with 10 mM fura-2 AM were depolarized with 30 mM KCl. K+-induced [Ca2+]i rise was measured in single cells and expressed as DF. Values
are the mean ± SEM of 129 cells from Tg(WT) and 286 cells from Tg(PG14) mice. ***p < 0.001 by Student’s t test.
(C) Representative pseudocolor images of fura-2 AM-loaded CGNs stimulated with 30 mM KCl. The images were taken before the stimulus (a and b), at an
intermediate (c and d), and at the peak response (e and f). The color scale is shown on the left. Scale bar, 50 mm.
(D) Representative whole-cell VGCC inward Ba2+ currents in response to 10mV increment step depolarizations from80 to 60mV recorded in CGNs from Tg(WT)
and Tg(PG14).
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Figure 4. Defective Calcium Influx in CGNs Is Due
to PG14 PrP Expression and Accumulation in
Secretory Organelles
(A) Primary CGNs fromC57BL/6J and Tg(PG14)micewere
transduced with 1–53 106 TU/ml of lentiviruses encoding
anti-PrP shRNA (LV-MW1 or LV-MW2), or with a lentivirus
lacking shRNA (LV-E). The depolarization-induced [Ca2+]i
rise was measured in lentivirus-exposed CGNs and ex-
pressed as DF. Each bar indicates the mean ± SEM of
cells transduced by the LV-E (40 C57BL/6J and 20 PG14
cells), LV-MW1 (19 C57BL/6J and 13 PG14 cells), and
LV-MW2 (9 C57BL/6J and 27 PG14 cells). **p < 0.01 and ***p < 0.001 by two-way ANOVA, Bonferroni’s post hoc test.
(B) Primary CGNs from C57BL/6J mice were transfected with pBUD-GFP plasmid carrying the wild-type, PG14, PG14/DHC, or DHC PrP cDNA. The K+-induced
[Ca2+]i rise was measured in GFP-positive cells and expressed as DF. Each bar is the mean ± SEM of 330 wild-type, 235 PG14, 299 PG14/DHC, and 192 DHC
PrP-expressing cells. ***p < 0.001 versus the corresponding value of Tg(WT) by one-way ANOVA, Bonferroni’s post hoc test.
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coimmunoprecipitated with a2d-1 (Figure S5C), indicating that
PrP region 114–121 was not essential for the interaction.
Next, we testedwhether the distribution of a2d-1 was altered in
cells expressing PG14 PrP. HeLa cells were cotransfected with
plasmids encoding the CaVa1A, CaVb4, and a2d-1 subunits, and
either wild-type or PG14 PrP-EGFP fusion proteins, and
analyzed by confocal microscopy after immunofluorescent
staining of a2d-1. Consistent with previous localization of nonflu-
orescent and EGFP-fused PrPs (Biasini et al., 2010; Fioriti et al.,
2005; Ivanova et al., 2001), themajority of wild-type PrP localized
on the cell surface (Figures 6A and 6J), whereas PG14 PrP was
mostly found in intracellular compartments (Figures 6D and
6J). In cells expressing wild-type PrP, a2d-1 was efficiently
expressed on the plasma membrane where it colocalized
with PrP (Figures 6B, 6C, and 6K). In contrast, a2d-1 was
weakly expressed on the surface of PG14 PrP-expressing
cells, and was mostly found in perinuclear patches where
it colocalized with PrP (Figures 6E, 6F, and 6K), and with ER
and Golgi markers (data not shown). This was seen in cells
with high or low expression levels, ruling out that the abnormal
localization of a2d-1 was due to overexpression. The CaVa1A
pore-forming subunit also accumulated intracellularly in
PG14 PrP-expressing cells (Figures S6A–S6H), whereas there
was no effect on the localization of 50 nucleotidase (50NT),
a raft-resident GPI-anchored protein that does not belong to
the VGCC complex (Davies et al., 2010) (Figures S6I–S6P). In
cells expressing PG14/DHC PrP, a2d-1 was more efficiently
delivered to the cell surface, indicating that intracellular retention
of mutant PrP played a role in the trafficking defect (Figures 6H,
6I, and 6K).
To demonstrate that intracellular PrP retention was directly
responsible, we analyzed the distribution of a2d-1 in cells ex-(E) Mean IV relationship of peak IBa recorded in CGNs from Tg(WT) and Tg(PG14), i
current densities (pA/pF) are shown as mean ± SEM; n = 17 for Tg(WT) and n =
(F) Voltage-dependent activation curves of VGCC currents generated in Tg(WT)
a repolarization to 40mV, normalizing to the largest tail current in the series an
(G) Cultured CGNs from wild-type (C57BL/6J) and Tg(PG14) mice were voltage c
1 ms depolarizing pulse to 30mV at 50 ms interpulse interval. Representative sa
(H) Amplitude of the first evoked EPSC in wild-type and PG14 neurons.
(I) The PPR value was calculated as the ratio of the amplitudes of the second to
Bars in (H) and (I) indicate the mean ± SEM of 10 wild-type and 11 PG14 cells. *pressing PrP molecules artificially targeted to the ER or Golgi.
HeLa cells were cotransfected with the CaVa1A, CaVb4, and
a2d-1 subunits, and with a modified version of wild-type PrP
in which the GPI signal had been replaced with the ER reten-
tion KDEL motif (PrP-ER) or with the transmembrane domain
from the rubella virus envelope glycoprotein E2, which
contains a Golgi-targeting signal (PrP-Golgi). Double-immuno-
fluorescent staining of PrP-ER with protein disulfide isom-
erase, and PrP-Golgi with giantin, confirmed the predicted
intracellular localization of these constructs (Figure 7A). In
cells expressing PrP-ER or PrP-Golgi, a2d-1 resided in intra-
cellular compartments, colocalizing with PrP (Figure 7B).
Thus, blocking PrP in the ER or Golgi by artificial retention
signals resulted in intracellular retention of a2d-1, as with the
PG14 mutation.
To investigate whether PG14 PrP expression impaired the cell
surface delivery of a2d-1 in neuronal cells too, we immunostained
endogenous a2d-1 in nonpermeabilized primary CGNs from
wild-type and PG14 mice. The immunofluorescent signal was
markedly lower in PG14 CGNs than in the wild-type control (Fig-
ure S7A); a2d-1 levels were similar in wild-type and PG14
neurons (Figure S7B), ruling out that the lower a2d-1 level on
the surface of PG14 CGNs was due to reduced a2d-1 expres-
sion. To test whether the synaptic localization of a2d-1 and
CaVa1A was altered in the cerebellum of Tg(PG14) mice, we as-
sessed their levels in purified synaptic membranes by western
blot. a2d-1 and CaVa1A levels were significantly lower in the cere-
bellar synaptosomal fractions of the mutant mice (Figures S7C
and S7D). In addition, immunofluorescent staining of the cere-
bellar molecular layer showed reduced colocalization of a2d-1
with VGLUT1 (Figure S7E), and of CaVa1A with the presynaptic
marker VAMP2 (Figure S7F) consistent with impaired VGCC
transport to synaptic sites.n response to 250ms voltage pulses in 10mV increments from80 to 60mV. IBa
10 for Tg(PG14).
(n = 8) and Tg(PG14) (n = 6) CGNs by measuring tail currents stimulated by
d then plotting against the prepulse voltage.
lamped at a holding potential of 70mV, and EPSCs were evoked by pairs of
mple traces are shown.
the first EPSC.
p < 0.05, ***p < 0.001 by Mann-Whitney U test.
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Figure 5. PrP and a2d-1 Are Coimmunoprecipitated from Brain
Extracts
(A) Cerebellar protein extracts (500 mg) from Tg(WT), Tg(PG14), and Prnp0/0
(KO) mice were incubated with uncoated magnetic beads (lanes 1–3) or
magnetic beads coated with anti-PrP monoclonal antibody 94B4 (lanes 4–6).
The immunoprecipitated proteins were analyzed by western blot with an anti-
a2d-1 antibody (upper panel) or anti-PrP polyclonal antibody P45-66 (lower
panels). The input (lanes 7–9) is 25 mg of total protein.
(B) Cerebellar protein extracts (500 mg) from the same animals as in (A) were
incubated with uncoupled magnetic beads (lanes 1–3) or magnetic beads
coated with anti-a2d-1 polyclonal antibody (lanes 4–6). The immunoprecipi-
tated proteins were analyzed by western blot with an anti-a2d-1 monoclonal
antibody (upper panel) or anti-PrP monoclonal antibody 12B2 (lower panels).
The input (lanes 7–9) is 25 mg of total protein.
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and Impairs Depolarization-Induced Calcium Influx and
Glutamate Release in Primary Neurons and Tg Mice
Next, we askedwhether another pathogenic PrPmutant affected
VGCC trafficking and function. Like PG14 PrP, mouse PrP
carrying the D177N/V128 mutation misfolds and accumulates
in the ER of CGNs, and in Tg mice it induces a CJD-like
syndrome with motor, cognitive, and electroencephalographic
abnormalities (Dossena et al., 2008). As was the case for the
PG14 mutation, expression of D177N PrP altered a2d-1 localiza-
tion in HeLa cells (Figures 8A–8C, 8G, and 8H). This was not seen
in cells expressing D177N/DHC PrP, which is more efficiently
delivered to the cell surface (Biasini et al., 2010) (Figures 8D–
8H), confirming that intracellular retention of mutant PrP plays
a role in the trafficking defect of a2d-1. CGNs from Tg(CJD)
mice expressing D177N/V128 PrP showed a lower depolariza-
tion-induced calcium influx (Figure 8I). Similar to that in
Tg(PG14) mice, [3H]D-aspartate release was reduced in cere-
bellar synaptosomes of Tg(CJD) mice with motor behavioral
abnormalities (Figures 8J and 8K).306 Neuron 74, 300–313, April 26, 2012 ª2012 Elsevier Inc.DISCUSSION
The cellular pathways activated by mutant PrP in genetic prion
diseases, ultimately leading to neuronal dysfunction and degen-
eration, are not known. Several mutant PrPs misfold soon after
synthesis in the ER and reside longer in transport organelles,
suggesting that misfolding and intracellular retention may play
a pathogenic role. In the present study we found that early motor
behavioral abnormalities in two different Tg mouse models
correlate with defective glutamatergic neurotransmission in
CGNs. This precedes neurodegeneration and is due to inefficient
VGCC-mediated calcium influx in presynaptic terminals. PrP
interacts with the VGCC a2d-1 subunit, which regulates the
forward trafficking of the channel. Due to mutant PrP retention
in transport organelles, a2d-1 accumulates intracellularly, result-
ing in inefficient targeting of the VGCC complex to synaptic sites.
These results provide a cell biological explanation for predege-
nerative cerebellar dysfunction in genetic prion diseases, and
suggest a possible physiological role of PrP in VGCC trafficking
and activity.
Impaired Cerebellar Glutamatergic Transmission
and Early Motor Disturbances
Analysis of motor performance on the Rotarod indicates that
motor abnormalities in Tg(PG14) mice emerge at 45 days of
age, long before kyphosis, foot clasp reflex, and the other
neurological signs typical of this model (Chiesa et al., 1998,
2000). At this stage we found no synaptic or granule cell loss
in the cerebellar cortex but a significant decrease of glutamate
release from presynaptic terminals, suggesting that mutant
PrP leads to perturbation of synaptic transmission independently
of neuronal death. Consistent with this, glutamate release was
impaired in CGNs isolated from Tg(PG14) mice, which remain
healthy in primary culture, and in cerebellar synaptosomes of
Tg(CJD) mice, which develop motor disease in the absence of
granule cell loss (Dossena et al., 2008). Thus, the onset of cere-
bellar dysfunction and neuron demise are dissociated in mutant
PrP mice, as in mouse models of spinocerebellar ataxia type-1
(Duvick et al., 2010).
In the cerebellar cortex, parallel fibers (PFs) from granule
neurons transmit excitatory glutamatergic inputs to dendrites
of Purkinje cells (PCs), which serve as the output system for
motor control (Ghez, 1991). Tg mice in which glutamate exocy-
tosis from PFs is selectively suppressed by conditional expres-
sion of tetanus neurotoxin in CGNs develop motor dysfunction
that can be rescued by switching off the neurotoxin expression
(Yamamoto et al., 2003), indicating a vital role of CGN glutama-
tergic transmission in sensorimotor function. Because mutant
PrP impairs glutamate release in CGNs, as documented by the
reduced depolarization-evoked exocytosis and changes in
short-term plasticity, the motor deficit in mutant mice is most
likely the consequence of inefficient excitatory inputs at the
PF-PC synapse.
A number of observations support the idea that synaptic
dysfunction induced by abnormal PrP is an important determi-
nant of early behavioral abnormalities in prion diseases. In
prion-infectedmice defects in presynaptic hippocampal function
precede neurodegeneration, and parallel the deficits in
Figure 6. a2d-1 Is Retained in Intracellular Compartments of Cells Expressing PG14 PrP
(A–I) HeLa cells were cotransfected with plasmids encoding wild-type, PG14, or PG14/DHCPrP-EGFP fusion protein, and the VGCC subunits CaVa1A, CaVb4, and
a2d-1 (0.5:3:2:2 ratio). After 48 hr, cells were fixed, permeabilized, stained with anti-a2d-1 monoclonal antibody followed by Alexa 594 (red)-conjugated anti-
mouse IgG secondary antibody, and reacted with DAPI (blue) to stain the nuclei. Scale bar, 20 mm. The fluorescent density of PrP-EGFP (J) and a2d-1 (K) on the
cell surface was measured and expressed as a percentage of the total. Each bar indicates the mean ± SEM of 28 wild-type, 48 PG14, and 8 PG14/DHC
transfected cells. **p < 0.01 and ***p < 0.001 by one-way ANOVA, Dunn’s post hoc test. n.s., not significant.
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such as recognition memory, burrowing, and nesting (Chiti
et al., 2006; Cunningham et al., 2003; Mallucci et al., 2007).
Intracellular Retention of Mutant PrP and VGCC
Dysfunction
Our results indicate that defective glutamate release in the cere-
bellum of Tg(PG14) mice is due to inefficient VGCC function in
CGNs, and that mutant PrP is directly responsible. Lentivirus-
mediated knockdown of PG14 PrP restored the depolarization-evoked calcium rise, and transfection of a plasmid encoding
PG14 PrP impaired the calcium response in wild-type neurons.
The latter observation indicates that PG14 PrP alters calcium
dynamics with a dominant effect over wild-type PrP, consistent
with a gain-of-toxicity mechanism. However, a loss of a putative
PrP function in governing VGCC activity (see below) may also be
involved.
Previous analyses suggested that accumulation of mutant PrP
in the secretory pathway might be critical in neuronal dysfunc-
tion, possibly due to interference with transport and delivery ofNeuron 74, 300–313, April 26, 2012 ª2012 Elsevier Inc. 307
Figure 7. Targeting PrP to the ER or Golgi
Induces Intracellular Accumulation of a2d-1
HeLa cells were cotransfected with plasmids
carrying cDNAs encoding PrP-ER or PrP-Golgi
and the VGCC subunits a1A, Cavb4, and a2d-1
(0.5:3:2:2 ratio).
(A) After 48 hr, cells were fixed, permeabilized, and
stained with anti-PrP monoclonal antibody 98A3
(green), and polyclonal antibodies against protein
disulfide isomerase (PDI) or giantin to stain the ER
or Golgi (red).
(B) Transfected cells were stained with anti-PrP
polyclonal antibody R505 (green) and an anti-
a2d-1 monoclonal antibody (red). Cells were re-
acted with DAPI (blue) to stain the nuclei.
Scale bars, 20 mm.
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Massignan et al., 2010; Medrano et al., 2008). Here, we found
that intracellular retention of mutant PrP was required for per-
turbing neuronal calcium dynamics, and identified the a2d-1
subunit of VGCCs as a target molecule. We documented a phys-
ical interaction between PrP and a2d-1 by coimmunoprecipita-
tion, and the two proteins colocalized in transfected cells,
consistent with analysis of the native PrP interactome, which
identified a2d subunits as candidate PrP interactors (Rutishauser
et al., 2009).
The a2d subunits play a vital role in intracellular trafficking of
the pore-forming CaVa1 subunits of the CaV1 and CaV2 classes,
and boost calcium current amplitude by increasing the number
of channels on the cell surface (Cantı´ et al., 2005). a2d interacts
with CaVa1 during biosynthetic maturation, and promotes the
transport of the heteromeric channel complex to correct presyn-
aptic sites (Bauer et al., 2010; Cantı´ et al., 2005; Hendrich et al.,
2008; Saheki and Bargmann, 2009). We found that a2d-1 and
CaVa1A were weakly expressed on the cell surface and localized
mainly in the ER and Golgi in mutant PrP-expressing cells, sug-
gesting impaired secretory transport. We also found smaller
amounts of a2d-1 and CaVa1A in cerebellar synaptosomal
fractions of Tg(PG14) mice, and reduced colocalization with
synaptic markers, consistent with inefficient targeting of the308 Neuron 74, 300–313, April 26, 2012 ª2012 Elsevier Inc.channel complex to axonal terminals of
granule neurons. Thus, the smaller depo-
larization-evoked calcium rise in cere-
bellar synaptosomes and in primary
CGNs can be explained by the fact that
there are fewer functional channels on
the plasma membrane.
We previously found that PG14 and
D177N PrP molecules with a deletion in
the hydrophobic core between residues
114–121 had less tendency to misfold
and were more efficiently delivered to
the cell surface than their full-length
counterparts, providing a model for as-
sessing the role of intracellular retention
in neurotoxicity (Biasini et al., 2010). Bycomparing the effect of HC-deleted and full-length molecules
on a2d-1 trafficking and calcium dynamics, we provided
evidence that VGCC dysfunction depends on intracellular reten-
tion of mutant PrP. This, and the fact that PrP interacts physically
with the a2d-1 subunit, suggests a mechanism whereby interac-
tion between mutant PrP and a2d-1 results in the latter being
sequestered in secretory organelles, impairing correct assembly
and delivery of the channel complex to synaptic sites.
Although this can readily explain the low levels of VGCCs
at presynaptic terminals, an indirect mechanism might also be
involved. PrP may participate in cell signaling governing
membrane protein transport (Ma´laga-Trillo et al., 2009) that
could be altered by pathogenic mutations. We did in fact find
that cells expressing D177N PrP had an impairment in Rab11-
dependent trafficking (Massignan et al., 2010), which could
potentially affect the endocytic recycling of a2d-1 (Tran-Van-
Minh and Dolphin, 2010).
Our analysis indicates that glutamatergic neurotransmission in
Tg(PG14) mice is preferentially impaired in CGNs, in line with the
selective expression of a2d-1 by these cells in the cerebellum
(Cole et al., 2005). However, a2d-1 is also expressed by glutama-
tergic neurons in other brain regions (Cole et al., 2005). There-
fore, there might be defects in a2d-1 transport and neurotrans-
mission in other neural systems, which could be responsible
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spatial working memory in Tg(CJD) mice (Dossena et al.,
2008) might depend on abnormal glutamatergic function in the
hippocampus.
Three different a2d subunits are expressed in functionally
distinct neurons of the brain, with the a2d-2 and a2d-3 isoforms
sharing, respectively, 55.6% and 30.3% sequence identity with
a2d-1 (Klugbauer et al., 1999). It will be interesting to see if PrP
interacts with a2d-2 and a2d-3, and if their cellular trafficking is
affected by mutant PrP, as with a2d-1. It will also be important
to see whether VGCC dynamics are perturbed in prion diseases
acquired by infection. N-type VGCC function is impaired in prion-
infected hypothalamic GT1-1 cells (Sandberg et al., 2004), but it
is not clear whether this is due to deficient channel insertion in
the plasma membrane.
At an advanced stage of disease, Tg(PG14) mice show
synaptic degeneration in the cerebellar molecular layer and
apoptosis of granule neurons, raising the possibility that func-
tional impairment of a2d subunits resulting from sequestration
by mutant PrP may eventually lead to synaptic disruption and
neuron demise. Consistent with this, targeted deletion or spon-
taneous mutation of the mouse Cacna2d2 gene encoding
a2d-2, which is primarily present in Purkinje neurons, results in
cerebellar ataxia with PC depletion and apoptosis of granule
neurons (Barclay et al., 2001; Ivanov et al., 2004). It is striking
that mutations in other VGCC subunits also often result in cere-
bellar degeneration in mice (Pietrobon, 2005), perhaps because
cerebellar neurons are more sensitive to changes in calcium
levels, or less able to activate compensatory responses than
neurons of other brain regions. In this regard the fact that
glutamate release was not consistently impaired in the cerebral
cortex of Tg(PG14) mice despite high a2d-1 expression (Cole
et al., 2005) may be due to upregulation of cellular pathways
that positively affect VGCC trafficking and activity (Simms and
Zamponi, 2012).
Possible Physiological Significance of the PrP-a2d-1
Interaction
Our findings that wild-type PrP and a2d-1 are coimmunoprecipi-
tated from mouse brain extracts and colocalize in transfected
cells suggest a role of PrP in VGCC function. In line with
this, cerebellar granules and hippocampal CA1 neurons lacking
PrP showed alterations in L-type VGCC-dependent calcium
dynamics (Fuhrmann et al., 2006; Herms et al., 2000). In addition,
treatment of synaptosomes with recombinant PrP resulted in
cytosolic calcium elevation that was inhibited by gadolinium—
a nonselective VGCC blocker—and an anti-PrPmonoclonal anti-
body impaired the calcium response to depolarization (Whatley
et al., 1995). Finally, exposure of neurons to full-length PrP or
N-terminal fragments affected L-type VGCC-mediated calcium
entry (Florio et al., 1998; Korte et al., 2003). Although we found
no significant deficits in depolarization-evoked calcium influx in
cerebellar synaptosomes from PrP-deficient mice, there was
a modest but significant decrease in primary CGNs lacking PrP
(data not shown), consistent with an effect on somatic channels
(predominantly L-type) (Herms et al., 2000).
PrP might regulate VGCC activity through several mecha-
nisms. Interaction with a2d-1 in the ER might titrate its associa-tion with CaVa1A and fine-tune the anterograde transport of the
channel complex. Alternatively, PrP may influence the channel
activity by associating with a2d-1 on the plasma membrane, or
acting as a scaffold protein to target the channel complex to
specific membrane microdomains (Madore et al., 1999). Like
other GPI-anchored proteins, a2d-1 is preferentially located in
detergent-resistant lipid rafts (Davies et al., 2006, 2010). This
lipid raft localization appears to be independent of the GPI-
anchoring motif (Robinson et al., 2011), suggesting that it may
rely on interaction with other raft-resident proteins, such as
PrP. Finally, the PrP-a2d-1 interaction may have a physiological
significance unrelated to the channel activity. Recent findings,
in fact, show that a2d-1 is involved in synaptogenesis (Eroglu
et al., 2009), a function in which PrP has also been involved
(Kanaani et al., 2005; Pantera et al., 2009; Santuccione et al.,
2005).
Clearly, further studies are required to establish the physiolog-
ical significance of the PrP-a2d-1 interaction. It will be critical
to identify the protein domain(s) involved in the interaction, and
any other interacting partners. In light of the dysfunctional
consequences of themutant PrP association with a2d-1, disrupt-
ing their binding might represent a means for therapeutic
intervention.EXPERIMENTAL PROCEDURES
Mice
The production of Tg mice expressing wild-type, PG14, and D177N/V128
mouse PrPs with an epitope for the monoclonal antibody 3F4 has already
been reported by Chiesa et al. (1998) and Dossena et al. (2008). In this study
we used Tg mice of the Tg(WT-E1+/+) line, which expresses about four times
the endogenous PrP level, referred to throughout the text as Tg(WT); we
also used Tg(PG14-A3+/) and Tg(D177N/V128-A21+/) mice expressing Tg
PrP at approximately one time, referred to as Tg(PG14) and Tg(CJD), respec-
tively. These mice were originally generated on a C57BL/6J X CBA/J hybrid
and were then bred with the Zurich I line of Prnp0/0 mice (Bu¨eler et al., 1992)
with a pure C57BL/6J background (European Mouse Mutant Archive, Monter-
otondo, Rome; EM:01723). C57BL/6J mice were purchased from Charles
River Laboratories.
All procedures involving animals were conducted according to European
Union (EEC Council Directive 86/609, OJ L 358,1; December 12, 1987) and
Italian (D.L. n.116, G.U. suppl. 40, February 18, 1992) laws and policies, and
were in accordance with the United States Department of Agriculture Animal
Welfare Act and the National Institutes of Health Policy on Humane Care
and Use of Laboratory Animals. They were reviewed and approved by the
Mario Negri Institute Animal Care and Use Committee that includes ad hoc
members for ethical issues (18/01-D, 18/01-C). Animal facilities meet interna-
tional standards and are regularly checked by a certified veterinarian who is
responsible for health monitoring, animal welfare supervision, experimental
protocols, and review of procedures.MRI
Animals were anesthetized with 1% isoflurane in a 30%:70% O2:N2O gas
mixture and imaged in a horizontal bore 7-Tesla USR preclinical MRI system
(BioSpec 70/30; Bruker BioSpin, Germany) with a shielded gradient insert
(BGA 12, 400mT/m; rise time, 110 us). A 7mmbirdcage resonator for RF trans-
mission and a 10 mm diameter single-loop receiver coil were used to receive
the signal. T2-weighted anatomical images of the mouse brain were acquired
with the following parameters: TR 2500 ms, TE 50 ms, RARE factor 16, FOV
3 3 1.5 3 1.5 cm, Matrix 256 3 102 3 102, voxel 0.147 3 0.117 3 0.147.
The scan time was approximately 25 min. The cerebellar volume was quanti-
fied using the ImageJ software (http://rsbweb.nih.gov/ij/).Neuron 74, 300–313, April 26, 2012 ª2012 Elsevier Inc. 309
Figure 8. The D177N PrP Mutation Alters a2d-1 Trafficking and Impairs Depolarization-Induced Calcium Influx and Glutamate Release
(A–F) HeLa cells were cotransfected with plasmids encoding D177N or D177N/DHC PrP-EGFP fusion protein, and the VGCC subunits CaVa1A, CaVb4, and a2d-1
(0.5:3:2:2 ratio). After 48 hr, cells were fixed, permeabilized, stained with anti-a2d-1 monoclonal antibody followed by Alexa 594 (red)-conjugated anti-mouse IgG
Neuron
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Weused an accelerating Rotarod 7650model (UgoBasile). Juvenile mice were
tested starting from 19 days of age (P19) for 7 consecutive days. On the first
day a training session was done during which each mouse was placed on
the Rotarod at a constant speed (4 rpm) for a maximum of 60 s. Then they
were assessed in three consecutive test sessions with a 10 min intertrial
resting period. They were positioned on the rotating bar and allowed to
become acquainted with the environment for 30 s. The rod motor was started
initially at 4 rpm and accelerated to 40 rpm at a constant rate of 0.12 rpm/s for
a maximum of 300 s. Adult mice were trained three times the week before offi-
cial testing. The performance was scored as latency to fall, in seconds.
Animals were given three trials, and the average was used for statistical
analysis.
Synaptosome Preparation
Synaptosomes were isolated from the cerebral cortex and the cerebellum
using a discontinuous Percoll gradient as described by Stigliani et al. (2006).
Cells
Primary CGNs were prepared from 6-day-old mice as described by Biasini
et al. (2010). HeLa cells were grown in a 1:1 mixture of Dulbecco’s modified
Eagle’s medium (DMEM) and minimal essential medium a (MEM), supple-
mented with GlutaMAX (Invitrogen), 10% FBS, nonessential amino acids
(Sigma-Aldrich), 100 U/ml penicillin, and 100 mg/ml streptomycin (GIBCO),
and maintained at 37C in 5% CO2/95% air. Plasmid transfections and trans-
duction with lentiviral vectors were done as described in the Supplemental
Experimental Procedures.
Biochemical Analyses
Detergent insolubility and immunoprecipitation with antibody 15B3 were
assayed as described by Biasini et al. (2009) and Chiesa et al. (1998). Coimmu-
noprecipitation was done as described in the Supplemental Experimental
Procedures.
Immunofluorescence Staining
Immunofluorescence staining of cells and brain sections was performed as
described in the Supplemental Experimental Procedures.
Antibodies
Antibodies used for western blot, immunoprecipitation, and immunofluores-
cence are described in the Supplemental Experimental Procedures.
Neurotransmitter Uptake and Release
Neurotransmitter uptake and release from synaptosomes and CGNs were
done according to published protocols by Stigliani et al. (2006), and are
described more fully in the Supplemental Experimental Procedures.
Calcium Measurements
Calcium levels in synaptosomes were determined spectrofluorimetrically after
incubating purified synaptosomes with the calcium-sensitive fluorescent dye
fura-2 AM. Synaptosomes washed in Tris/acetate buffer (128 mM NaCl,
5 mM KCl, 1 mM MgSO4, 1.5 mM NaHPO4, 10 mM glucose, 10 mM Tris/HCl
[pH 7.4]) were resuspended at a total protein concentration of 1 mg/ml and
loaded with fura-2 AM 5 mM at 37C for 30 min in Tris/acetate buffer plussecondary antibody, and reacted with DAPI (blue) to stain the nuclei. Scale bar, 20
wasmeasured and expressed as a percentage of the total. Each bar indicates the
Mann-Whitney U test.
(I) Primary cultures of CGNs fromC57BL/6J (wild-type) and Tg(CJD)mice were pre
[Ca2+]i rise was measured in single cells and expressed as DF. Values are the me
independent experiments. ***p < 0.001 by Student’s t test.
(J) Depolarization-induced [3H]D-aspartate release was determined in cerebellar
indicates the mean ± SEM of 2 independent analyses (18 superfusion chambers
**p < 0.01 versus the corresponding values of Tg(WT) by Student’s t test.
(K) Groups of 9–20 C57BL/6J (wild-type) and 3–12 Tg(CJD) mice were tested on
mean latency to fall was calculated. Bars indicate the mean ± SEM latency to faBSA 1%. After centrifugation at 16,000 3 g for 5 min, synaptosomes were
resuspended at a final protein concentration of 0.25 mg/ml in Tris/acetate buffer
plus 1 mM CaCl2 and aliquoted in 96-well plates (50 mg protein/well). Fluores-
cence was measured at 37C for 200 cycles, each cycle alternating excitation
at 340 and 380 nm and monitoring emission at 510 nm. Depolarization was
induced by injecting 50 mM KCl at cycle 50. The fluorescence ratio
F340:380 was measured for each cycle, and data were reported as DF340/
380, the difference between F340/380 before and after the stimulus, which
is proportional to the KCl-induced Ca2+ influx. Single-cell calcium imaging
was done as described by Verderio et al. (2004) using an Olympus IX81
inverted microscope equipped with a calcium imaging unit (CellR; Olympus).
Electrophysiology
Whole-cell VGCC currents were recorded from CGNs as described by Con-
dliffe et al. (2010). For evoked and miniature EPSC recordings, CGNs were
bathed in an external solution containing 125 mM NaCl, 5 mM KCl, 1.2 mM
MgSO4, 2 mM CaCl2, 1.2 mM KHPO4, 25 mM HEPES, 10 mM Glu (pH 7.4).
For miniature recordings 1 mM tetrodotoxin was added. Patch pipettes were
filled with internal solutions (130 mM KGluc, 1 mM EGTA, 10 mM KCl, 2 mM
MgCl2, 10 mM HEPES, 4 mM Mg-ATP, and 0.3 mM Tris-GTP). EPSCs for
paired pulse recordings were evoked frommonosynaptically coupled neurons
by pairs of 2 ms depolarizing pulses from 70 to 30mV (50 ms interpulse
interval [20 Hz]) every 5 s. During miniature EPSCs and paired-pulse record-
ings, cells were held at 70mV (unless otherwise stated). Series resistance
ranged from 10 to 20 MU and was monitored for consistency during record-
ings. Cells in culture with leak currents >100 pA were excluded from the anal-
ysis. Signals were amplified, sampled at 10 kHz, filtered to 2 or 5 KHz, and
analyzed using pClamp 10 data acquisition and analysis program.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.neuron.2012.02.027.
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